<DOC>
	<DOCNO>NCT02542228</DOCNO>
	<brief_summary>This research do construct survey questionnaire , quality life tool , determine health , well-being , ability perform daily activity , physical , social emotional functioning participant primary immunodeficiency disorder ( PIDD ) . This quality life ( QOL ) tool help physician understand effect PIDD person 's health . These quality life survey important tool physician measure outcomes satisfaction effect treatment .</brief_summary>
	<brief_title>Construction Health-related Quality Life ( HR-QOL ) Questionnaire Patients With Primary Antibody Deficiency Disease</brief_title>
	<detailed_description>A preliminary patient clinician-generated scale validate modified multicenter scale validity study involve 85 patient 5 site . Feasibility survey conduct available site include study include Boston Children's/ Harvard , Midwest Immunology , Johns Hopkins , Children 's Hospital Baylor University , University South Florida All Children 's Hospital Johns Hopkins Medicine . Patients enrol clinic non-infusion visit . The purpose study explain informed consent obtain . A case report form ( CRF ) clinical condition demographic complete base information obtain local study coordinator interview time visit . The HR-QOL PIDD survey administer patient site PI study coordinator . A second survey hand patient take home complete 48-120 hr . clinic visit . The study coordinator contact patient period ensure patient completes second survey return local study site . If patient SCIg ask take survey 3 day SC infusion ( weekly ) , complete pair survey 48-72 hr later ( another SCIg infusion schedule ) . The study coordinator obtain interim history period pair survey ensure , general , condition patient change could invalidate validation process , information document addendum case report form ( CRF ) . Patient return survey site study coordinator either mail , fax electronically scan document . Paired survey return central study site ( USF St Petersburg ) data input .</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Deficiency Diseases</mesh_term>
	<mesh_term>Common Variable Immunodeficiency</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<criteria>1 . Subjects document xlinked agammaglobulinemia , common variable immunodeficiency , autosomal recessive agammaglobulinemia 2 . Subjects must able read speak English 3 . Willing sign consent follow study schedule . 4 . Subjects 18 year 65 year age . 5 . Subject must receive Ig treatment diagnosis . 1 . Subject guardian unwilling sign consent adhere study schedule . 2 . Pregnancy , 3 . Severe concurrent medical condition would prevent treatment assessment , include significant hematological , renal , lung liver dysfunction malignancy 4 . Presence medical condition , opinion investigator might interfere performance interpretation study 5 . Can read understand English</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Immune Deficiency , antibody</keyword>
	<keyword>Quality Life survey</keyword>
</DOC>